Document is current

Any future updates will be listed below

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

Crossref DOI link: https://doi.org/10.1186/s12879-017-2517-3

Published: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark